Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BTCY NASDAQ:CTCX NASDAQ:IVF NYSE:RMED On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTCYBiotricity$0.39-0.8%$0.45$0.19▼$0.83$9.59M1.1137,094 shs59,775 shsCTCXCarmell$2.83-3.1%$3.01$0.17▼$1.27$59.16M0.514.65 million shs14,980 shsIVFINVO Fertility$1.84+1.1%$3.31$1.61▼$51.12$1.31M1.993.62 million shs887,806 shsRMEDRa Medical Systems$0.73$0.52▼$11.14$3.19M-0.03197,480 shs77,500 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTCYBiotricity-0.77%-20.45%-1.28%-23.00%-44.26%CTCXCarmell0.00%-28.08%+19.18%+1,669.70%+175.47%IVFINVO Fertility+1.10%-17.86%-27.38%-65.93%-94.32%RMEDRa Medical Systems0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBTCYBiotricityN/AN/AN/AN/AN/AN/AN/AN/ACTCXCarmellN/AN/AN/AN/AN/AN/AN/AN/AIVFINVO FertilityN/AN/AN/AN/AN/AN/AN/AN/ARMEDRa Medical SystemsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBTCYBiotricity 2.00HoldN/AN/ACTCXCarmell 0.00N/AN/AN/AIVFINVO Fertility 0.00N/AN/AN/ARMEDRa Medical Systems 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBTCYBiotricity$12.06M0.80N/AN/A($1.30) per share-0.30CTCXCarmell$32.84K1,801.55N/AN/A$1.07 per share2.64IVFINVO Fertility$6.53M0.20N/AN/A($89.58) per share-0.02RMEDRa Medical Systems$10K0.00N/AN/A$4.29 per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBTCYBiotricity-$14.09M-$0.67N/A∞N/A-80.42%N/A-188.47%8/18/2025 (Estimated)CTCXCarmell-$15.44MN/A0.00∞N/AN/A-217.50%-50.22%N/AIVFINVO Fertility-$9.10M-$102.18N/A∞N/A-377.73%N/A-88.18%N/ARMEDRa Medical Systems-$26.86M-$92.36N/AN/AN/AN/A-496.57%-344.49%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBTCYBiotricityN/AN/AN/AN/AN/ACTCXCarmellN/AN/AN/AN/AN/AIVFINVO FertilityN/AN/AN/AN/AN/ARMEDRa Medical SystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBTCYBiotricityN/A0.230.10CTCXCarmellN/A0.310.29IVFINVO FertilityN/A0.080.07RMEDRa Medical SystemsN/A2.862.85Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBTCYBiotricity3.89%CTCXCarmell24.22%IVFINVO Fertility12.02%RMEDRa Medical Systems11.00%Insider OwnershipCompanyInsider OwnershipBTCYBiotricity10.10%CTCXCarmell29.00%IVFINVO Fertility0.57%RMEDRa Medical Systems18.62%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBTCYBiotricity4024.91 million22.08 millionOptionableCTCXCarmell1420.91 million14.84 millionNot OptionableIVFINVO Fertility25720,000716,000No DataRMEDRa Medical Systems145.37 million4.37 millionNot OptionableRMED, BTCY, CTCX, and IVF HeadlinesRecent News About These CompaniesSetPoint Medical Announces Late-Breaking Data from RESET-RA Study at ACR Convergence 2024November 19, 2024 | businesswire.comIntercorp Financial Servs (NYSE:IFS) Stock Quotes, Forecast and News SummaryOctober 20, 2024 | benzinga.comRA Activity and Disease Control Assessment via Telehealth MetricsOctober 11, 2024 | physiciansweekly.comPMedical device maker, physicians, to pay $8M+ in kickback schemeSeptember 28, 2024 | beckersasc.comBCT-based radiomics nomogram can ID RA-linked interstitial lung diseaseSeptember 6, 2024 | medicalxpress.comMRa Medical Systems Inc (4RM.BE)August 18, 2024 | uk.finance.yahoo.comChina Medical System: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in ChinaAugust 6, 2024 | markets.businessinsider.comIn RA Treatment, Don't Overlook Underlying CV RisksMay 16, 2024 | medscape.comMMercy Medical Center Dr. Wright discusses Rheumatoid Arthritis in womenApril 28, 2024 | wbaltv.comWDietary Interventions Reduce CVD Risk in RA and SpAMarch 8, 2024 | ajmc.comAAlert1 Medical Alert System Review: What Experts Say (2024)February 20, 2024 | forbes.comRa Medical Systems Inc.February 15, 2024 | thestreet.comCatheter Precision Inc (VTAK)February 11, 2024 | investing.comVTAK Catheter Precision, Inc.January 19, 2024 | seekingalpha.comWhat Is The Life Expectancy Of Rheumatoid Arthritis? A Review By DoctorsJanuary 7, 2024 | msn.comCatheter Precision Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-QAugust 25, 2023 | finance.yahoo.comReminder: Ra Medical Systems Announces Name and Ticker Symbol ChangesAugust 17, 2023 | finance.yahoo.comRa Medical Systems, Inc.: Ra Medical Systems Announces Allowance of New Closure Device PatentAugust 16, 2023 | finanznachrichten.deRa Medical Systems Announces Milestone Achievement for Electrophysiology DivisionAugust 7, 2023 | finance.yahoo.comRa Medical Systems, Inc.: Ra Medical Systems Announces Proposed Name and Ticker Symbol ChangesAugust 2, 2023 | finanznachrichten.deNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military Spend3 Short Squeeze Candidates With Big Catalysts on the HorizonBy Dan Schmidt | July 25, 2025View 3 Short Squeeze Candidates With Big Catalysts on the HorizonHow a Government Loan Changes the Game for Plug PowerBy Jeffrey Neal Johnson | July 4, 2025View How a Government Loan Changes the Game for Plug PowerWhy Wall Street Is Betting on These 3 Comeback StocksBy Nathan Reiff | July 12, 2025View Why Wall Street Is Betting on These 3 Comeback StocksThe Bottom Is in for Kohl’s, But Let the Share Price Come to YouBy Thomas Hughes | July 23, 2025View The Bottom Is in for Kohl’s, But Let the Share Price Come to YouRMED, BTCY, CTCX, and IVF Company DescriptionsBiotricity NASDAQ:BTCY$0.38 0.00 (-0.77%) As of 08/1/2025 03:41 PM EasternBiotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.Carmell NASDAQ:CTCX$2.83 -0.09 (-3.08%) As of 08/1/2025Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. In addition, the company is also developing a line of men's products and a line of topical haircare products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Therapeutics Corporation and changed its name to Carmell Corporation in November 2023. Carmell Therapeutics Corporation was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.INVO Fertility NASDAQ:IVF$1.84 +0.02 (+1.10%) As of 08/1/2025 04:00 PM EasternINVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.Ra Medical Systems NYSE:RMEDRa Medical Systems, Inc develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. Ra Medical Systems, Inc is based in Fort Mill, South Carolina. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale AbbVie Stock Eyes Breakout as Pipeline and Profits Grow Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.